VEGFA and breast cancer: Conversely, loss of RAB25 is associated with a poor prognosis in ER-negative breast cancer, and RAB25 behaves as a tumor suppressor in breast cancer cell lines by decreasing cell migration/invasion and affecting pathways including the VEGF-A/VEGFR-1 autocrine loop [40].